Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 4.97K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -48.63k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -86.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -99.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -100.00% |
| Recommedations | - | Quick Ratio | - | Shares Outstanding | 2.49M | 52W Low Chg | - |
| Insider Own | 1,005.93% | ROA | - | Shares Float | 3.65M | Beta | 2.35 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00010 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 1,543 | Target Price | - |
| Oper. Margin | - | Earnings Date | - | Volume | 1 | Change | 0.00% |
About BIOHEMP INTERNATIONAL INC
BioHemp International, Inc. focuses on operating in the fast-growing consumer hemp and cannabidiol (CBD) market through a strategic rollup of CBD distributors. It focuses on the creation of distribution platform for CBD providers. The company was formerly known as Blake Insomnia Therapeutics, Inc. and changed its name to BioHemp International, Inc. in June 2019. BioHemp International, Inc. was founded in 2012 and is based in New York, New York.